Introduction {#sec1-1}
============

Lead, a dangerous heavy metal, is harmful even in small amounts. Nevertheless, humans get exposed to Pb through their environment and diet.\[[@CIT1]\] The manifestations of Pb poisoning in humans are nonspecific. They may include weight loss, anemia,\[[@CIT2][@CIT3]\] memory loss,\[[@CIT4]\] nephropathy, infertility,\[[@CIT5]\] etc. However, oxidation accompanies lead toxicity.\[[@CIT6]\] Tomato, on the contrary, is a source of antioxidants\[[@CIT7][@CIT8]\] and is made up of components very appropriate for detoxification, illnesses prevention,\[[@CIT9]\] attaining growth,\[[@CIT10]\] helping the immunologic system,\[[@CIT11]\] maintaining blood in good state,\[[@CIT2]\] etc.

This research, therefore, focuses on whether oral administration of cooked tomatoes prevents Pb- induced testicular toxicity or not.

MATERIALS AND METHODS {#sec1-2}
=====================

Fifteen (15) adult male Sprague Dawley rats (180 g--220 g) were used for this study. They were inbred at the Animal House section of the Department of Physiology, Ladoke Akintola University of Technology, Ogbomoso. The animals were acclimatized over a period of 2 weeks.

Preparation of tomato paste {#sec2-1}
---------------------------

Tomato paste (TP) was prepared by grinding tomatoes and heating in a water bath for 45 min at 80°C.

Grouping of animals and treatment {#sec2-2}
---------------------------------

The rats were grouped into three groups (Groups A, B, and C, n = 5). Animals in Group A served as the control group and were drinking distilled water. Animals in Groups B and C were drinking 1% Pb (II) acetate (LA).\[[@CIT12]\] Group C animals were, in addition to drinking LA, treated with 1.5 ml of TP/day*.* All treatments were for 8 weeks.

Animal sacrifice and collection of samples {#sec2-3}
------------------------------------------

Twenty-four hours after the last treatment, each animal was sacrificed by cervical dislocation and blood samples were collected via heart puncture. Blood sample obtained from each rat was divided into two: One half in a plain bottle and the other half in an ethylenediamminetetraacetic acid bottle. Plasma and serum were obtained by centrifugation at 3000 rpm for 20 min (g = 9.78 m/s^2^). Testis and caudal epididymis were excised from each rat.

Collection of data and statistical analysis {#sec2-4}
-------------------------------------------

One testis from each rat was homogenized for tissue superoxide dismutase (SOD), catalase (CAT) and malondialdehyde (MDA) and sperm count (SC) was carried out from the epididymis. Plasma and tissue SOD activities were determined using the method described by Fridovich (1986).\[[@CIT13]\] Plasma and tissue CAT activities were determined using the method described by Sinha (1972).\[[@CIT14]\] Plasma and tissue MDA concentrations were determined using the procedure described by Varshney and Kale (1990).\[[@CIT15]\]

The data obtained are presented as mean ± SD. The "Control Group" and the "Test Groups" were compared using the Mann-Whitney *U*-test. The significance level was set to a *P*-value \< 0.05.

RESULTS {#sec1-3}
=======

The following results were obtained and are presented as mean ± SEM. Level of significance is taken at "*P*-value \< 0.05" (\*) and/or "*P*-value \< 0.01" (\*\*).

Weight increase \[g (Equivalent g is 9.87 m/s^2^)\] {#sec2-5}
---------------------------------------------------

Comparing their final and initial weights showed that there was significant weight gain (*P*-value \< 0.05) in all the groups over the 8 weeks of the research. There was, however, no significant (*P*-value \>0.05) difference in weight gain across the three groups \[[Table 1](#T0001){ref-type="table"}\].

###### 

Weight increase across the three groups during the 10 weeks of research

                                           Group A        Group B         Group C
  ---------------------------------------- -------------- --------------- ---------------
  Weight before sacrifice (g)              213 ± 0.620    200.4 ± 0.855   221.4 ± 0.367
  Initial weight (g)                       186 ± 0.551    186.2 ± 0.549   185.6 ± 0.632
  Weight increase (g)                      27.0 ± 0.582   14.2 ± 0.694    35.8 ± 0.712
  *P*-value (when compared with control)                  0.0754          0.1548

Testicular weight \[g (Equivalent g is 9.87 m/s^2^)\] {#sec2-6}
-----------------------------------------------------

The testicular weight of Group C showed no significant (*P*-value \>0.05) difference from that of the control while the testicular weight of Group B was found to be significantly (*P*-value \< 0.05) lower than that of the control \[[Table 2](#T0002){ref-type="table"}\].

###### 

Comparison of testicular weight across the groups

                                           Group A          Group B                                              Group C
  ---------------------------------------- ---------------- ---------------------------------------------------- ----------------
  Testicular weight (g)                    0.6071 ± 0.044   0.5494 ± 0.024[^\*^](#T000F1){ref-type="table-fn"}   0.6163 ± 0.051
  *P*-value (when compared with control)                    0.0278                                               0.5000

"*P*-value \<0.05"

SC {#sec2-7}
--

SC for Group B was significantly (*P*-value \< 0.01) lower than that of the control whereas SC for Group C showed no significant difference (*P*-value \>0.05) from that of the control \[[Table 3](#T0003){ref-type="table"}\].

###### 

Comparison of sperm count (million cells/mm^3^) across the groups

                                           Group A         Group B                                               Group C
  ---------------------------------------- --------------- ----------------------------------------------------- ---------------
  Sperm count (million cells/mm^3^)        128.4 ± 0.349   14.00 ± 0.443[^\*\*^](#T000F2){ref-type="table-fn"}   125.4 ± 0.631
  *P*-value (when compared with control)                   0.0040                                                0.3452

"*P*-value \<0.01"

Life--death ratio of sperm cells {#sec2-8}
--------------------------------

Life--death ratio (LDR) of Group B was found to be significantly (*P*-value \<0.01) lower than that of the control whereas Group Cshowed no significant (*P*-value \>0.05) difference from the control \[[Table 4](#T0004){ref-type="table"}\].

###### 

Comparison of life--death ratio of sperm cells across the three groups

                                           Group A       Group B                                              Group C
  ---------------------------------------- ------------- ---------------------------------------------------- -------------
  Life--death ratio of sperm cells         5.1 ± 0.161   1.12 ± 0.081[^\*\*^](#T000F3){ref-type="table-fn"}   5.0 ± 0.178
  *P*-value (when compared with control)                 0.0040                                               0.4206

"*P*-value \<0.01"

Sperm motility (SM) {#sec2-9}
-------------------

Group B had SM that was significantly (*P*-value \<0.01) lower than that of the control whereas SM for Group C was not significantly (*P*-value \>0.05) different from that of the control \[[Table 5](#T0005){ref-type="table"}\].

###### 

Comparison of sperm motility across the three groups

                                           Group A        Group B                                              Group C
  ---------------------------------------- -------------- ---------------------------------------------------- --------------
  Sperm motility                           76.0 ± 0.409   11.0 ± 0.468[^\*\*^](#T000F4){ref-type="table-fn"}   76.0 ± 0.511
  *P*-value (when compared with control)                  0.0039                                               0.500

"*P*-value \<0.01"

Sperm morphology (SMP) {#sec2-10}
----------------------

Group B had SMP that was significantly (*P*-value \<0.01) poor compared with that of the control. Group C, however, showed no significant (*P*-value \>0.05) distortion in morphology \[[Table 6](#T0006){ref-type="table"}\].

###### 

Sperm morphology across the groups

                                           Group A        Group B                                              Group C
  ---------------------------------------- -------------- ---------------------------------------------------- --------------
  Sperm morphology                         75.0 ± 0.376   13.0 ± 0.477[^\*\*^](#T000F5){ref-type="table-fn"}   72.0 ± 0.478
  *P*-value (when compared with control)                  0.0041                                               0.2103

"*P*-value \<0.01"

Serum testosterone level (STL) {#sec2-11}
------------------------------

There was no significant (*P*-value \>0.05) difference between STL of control and that of Groups B and C \[[Table 7](#T0007){ref-type="table"}\].

###### 

Serum testosterone level across the groups

                                           Group A        Group B        Group C
  ---------------------------------------- -------------- -------------- --------------
  Serum testosterone level (ng/ml)         24.8 ± 0.256   24.4 ± 0.288   24.6 ± 0.246
  *P*-value (when compared with control)                  0.3452         0.5542

Plasma SOD activity {#sec2-12}
-------------------

Group B showed a significant (*P*-value \<0.01) decrease in plasma SOD activity. Group C was, however, not significantly (*P*-value \>0.05) different from the control in terms of the plasma SOD activity \[[Table 8](#T0008){ref-type="table"}\].

###### 

Plasma SOD activity across the groups

                                           Group A         Group B                                               Group C
  ---------------------------------------- --------------- ----------------------------------------------------- ---------------
  Plasma SOD activity                      1.658 ± 0.060   1.255 ± 0.074[^\*\*^](#T000F6){ref-type="table-fn"}   1.679 ± 0.065
  *P*-value (when compared with control)                   0.0023                                                0.4206

"*P*-value \<0.01"

Plasma CAT activity {#sec2-13}
-------------------

Group B showed a significant (*P*-value \<0.01) decrease in the plasma CAT activity. However, Group C showed no significant (*P*-value \>0.05) difference in the CAT activity from the control \[[Table 9](#T0009){ref-type="table"}\].

###### 

Plasma CAT activity across the groups

                                           Group A          Group B                                                Group C
  ---------------------------------------- ---------------- ------------------------------------------------------ ----------------
  Plasma CAT activity                      0.3954 ± 0.036   0.2670 ± 0.041[^\*\*^](#T000F7){ref-type="table-fn"}   0.3962 ± 0.045
  *P*-value (when compared with control)                    0.0033                                                 0.3452

"*P*-value \<0.01"

Plasma MDA concentration {#sec2-14}
------------------------

Group B showed a significant (*P*-value \<0.05) increase in the plasma MDA concentration whereas Group C showed no significant (*P*-value \>0.05) difference from the control \[[Table 10](#T0010){ref-type="table"}\].

###### 

Plasma MDA concentration across the groups

                                            Group A          Group B                                             Group C
  ----------------------------------------- ---------------- --------------------------------------------------- ---------------
  Plasma MDA concentration (μg/g protein)   1371.5 ± 3.013   1627.3 ± 1.87[^\*^](#T000F8){ref-type="table-fn"}   1432.4 ± 2.20
  *P*-value (when compared with control)                     0.0453                                              0.1547

"*P*-value \<0.05"

Testicular SOD activity {#sec2-15}
-----------------------

Group B showed a significant (*P*-value \<0.01) decrease in testicular SOD activity. There was, however, no significant (*P*-value \>0.05) difference in the testicular SOD activity of Group C from that of the control \[[Table 11](#T0011){ref-type="table"}\].

###### 

Testicular SOD activity across the groups

                                           Group A         Group B                                               Group C
  ---------------------------------------- --------------- ----------------------------------------------------- ---------------
  Testicular SOD activity                  1.529 ± 0.084   1.224 ± 0.060[^\*\*^](#T000F9){ref-type="table-fn"}   1.383 ± 0.087
  *P*-value (when compared with control)                   0.0079                                                0.2103

"*P*-value \<0.01"

Testicular CAT activity {#sec2-16}
-----------------------

Group B showed a significant (*P*-value \<0.05) decrease in the testicular CAT activity. However, Group C showed no significant (*P*-value \>0.05) difference from the control \[[Table 12](#T0012){ref-type="table"}\].

###### 

Testicular CAT activity across the groups

                                           Group A           Group B                                               Group C
  ---------------------------------------- ----------------- ----------------------------------------------------- ----------------
  Testicular CAT activity                  0.3725 ± 0.0267   0.2392 ± 0.056[^\*^](#T000F10){ref-type="table-fn"}   0.3352 ± 0.029
  *P*-value (when compared with control)                     0.0278                                                0.3452

"*P*-value \<0.05"

Testicular MDA concentration {#sec2-17}
----------------------------

Group B showed a significant (*P*-value \<0.01) increase in tissue MDA concentration whereas the MDA concentration in Group C was found to be significantly lower when compared with the control \[[Table 13](#T0013){ref-type="table"}\].

###### 

Table 13: Testicular MDA concentration across the three groups

                                                Group A           Group B                                                  Group C
  --------------------------------------------- ----------------- -------------------------------------------------------- -----------------
  Testicular MDA concentration (μg/g protein)   1393.47 ± 2.818   2235.47 ± 3.732[^\*\*^](#T000F11){ref-type="table-fn"}   1485.53 ± 2.655
  *P*-value (when compared with control)                          0.0039                                                   0.2103

"*P*-value \<0.01"

DISCUSSION {#sec1-4}
==========

The results of this study shows that 8 weeks of exposure to Pb does not significantly (*P*-value \>0.05) affect weight gain in rats, as against the findings of Suzan *et al.,* 1999\[[@CIT16]\] that chronic (12 weeks or more) exposure to Pb significantly (*P*-value \<0.05) reduces weight gain. Therefore, exposure to Pb for a longer period is expected to significantly reduce weight gain. On the contrary, a significant (*P*-value \<0.05) decrease was noticed in the testicular weight even for the 8 weeks of exposure. This ability of Pb to reduce weight gain and organ weight can be linked to the less-efficient metabolic processes associated with Pb toxicity.\[[@CIT17]\] However, there was no significant (*P*-value \>0.05) decrease in the testicular weight of animals treated with TP along with Pb exposure (Group C). This means that oral aadministration of 1.5 ml TP/day annuls adverse effect of Pb on weight gain. This may be partly due to the fatty acid composition of TP\[[@CIT18]\] and, more importantly, due to the presence of health-protective antioxidants such as lycopene, vitamin C, and vitamin A in TP,\[[@CIT8]\] despite its relatively low caloric value (21 Kcal/100 g) and low protein content (0.85% by weight).\[[@CIT19]\]

There was no significant (*P*-value \>0.05) decrease in the SC of animals treated with TP even though they were well exposed to Pb. On the contrary, the SC of the lead-only group (Group B) was significantly (*P*-value \<0.01) lower than that of the control. This is because Pb (as well as most other heavy metals) interferes with the male reproductive system,\[[@CIT16]\] specifically with the testicular functions,\[[@CIT20][@CIT21]\] which are the determinants of SC. The administered tomato would therefore be responsible for the prevention of these lowering effects of Pb on SC by preventing its adverse effects on testicular functions.

In a similar way, the LDR of sperm cells of animals treated with tomato along with Pb was not significantly different (*P*-value \>0.05) from that of the control whereas animals treated with Pb only showed a significant (*P*-value \<0.01) decrease in the LDR. Therefore, TP must have somehow prevented the adverse effects of Pb on LDR, such that there was no significant difference in LDR of the control and that of the Pb + TP group. This is most likely due to the detoxification effect of TP, as accounted for by The world of plants, 2008.\[[@CIT19]\]

SM was significantly (*P*-value \<0.01) reduced in animals treated with Pb only. This observation is in support of the findings of Ping-Chi *et al.*, 1998,\[[@CIT22]\] that lead exposure might reduce SM. However, the SM of animals treated with TP along with Pb is not significantly different from that of the control. This further establishes the fact that TP has a protective ability against Pb toxicity. In a similar way, SMP was significantly (*P*-value \<0.01) lowered in animals treated with Pb only. This observation is in support of the findings of Spomenka *et al.*, 2000,\[[@CIT23]\] and that of Pinon-Lataillade*et al.*, 1995,\[[@CIT24]\] that Pb causes an increase in abnormal sperm head morphology. However, the SMP of animals treated with TP along with Pb is not significantly different from that of the control. This also supports the fact that TP has a protective ability against Pb toxicity.

On the contrary, the STL of animals exposed to lead only was found not to be significantly (*P*-value \>0.05) different from STL of the control. This is in support of the findings of Pinon-Lataillade *et al.*, 1995,\[[@CIT24]\] that Pb does not affect the levels of follicle stimulating hormone and LH in blood and that of testosterone in both blood and testes. This, therefore, suggests that the hypothalamic--pituitary--testicular axis is not adversely affected by exposure to lead. In a similar way, the STL of animals treated with TP along with Pb was not significantly (*P*-value \>0.05) different from that of the control, which means that the effects of Pb and/or TP noticed on the male reproductive system were not as a result of changes/alteration in the plasma or testicular testosterone levels.

There was no significant (*P*-value \>0.05) difference in the SOD activity of both the plasma and the testes of the control and that of the animals treated with tomato along with Pb. But, there was a significant (*P*-value \<0.01) decrease in the plasma and testicular SOD activity in animals treated with Pb only compared with the control. This finding is in agreement with that of Ping-Chi and Yueliang (2002)\[[@CIT25]\] and is at the same time in support of *Lycopersicon esculentum* (tomato) as an antioxidant.

There was a significant (*P*-value \<0.05) decrease in both plasma and testicular CAT activity of animals treated with Pb only relative to the control. There was, however no significant (*P*-value \>0.05) difference between the control and the animals treated with tomato along with Pb in this respect. This further establishes that TP must have reduced the oxidative stress that Pb could cause.

Finally, there was no significant (*P*-value \>0.05) difference in both the plasma and the testicular MDA concentration of the control and those of the animals treated with tomato along with Pb, whereas animals treated with Pb only showed a significant (*P*-value \<0.05) increase in both plasma and testicular MDA concentration. This confirms that it was TP, the source of antioxidants,\[[@CIT7][@CIT8]\] that reduced the oxidative stress that Pb exposure could have caused in the tomato-treated animals.

It can, therefore, be concluded that exposure to lead significantly reduces testicular weight, SC, LDR, SM, and SMP while TP prevents these adverse effects of Pb on the male reproductive parameters. However, neither Pb alone nor Pb with TP could have any significant effect on the serum and testicular testosterone level. These adverse effects of Pb on the male reproductive parameters is most likely due to the oxidative stress that Pb causes by interfering with the activities of SOD and that of CAT and 35 thereby, given freedom to free radicals (e.g., reactive oxygen species) to cause oxidation, which manifests as an increase in the concentration of MDA (in the case of lipid peroxidation). TP, therefore, prevents the adverse effects of Pb on the male reproductive functions. This is due to the antioxidant property of TP.
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